Independent association between rate of clearance of infection and clinical outcome of hiv-associated cryptococcal meningitis: Analysis of a combined cohort of 262 patients

Clinical Infectious Diseases

Volumn 49, Issue 5, 2009, Pages 702-709

  Bicanic, Tihan A ^a,d,e,f   Muzoora, Conrad ^g   Brouwer, Annemarie E ^h   Meintjes, Graeme ^e,f   Longley, Nicky ^a   Taseera, Kabanda ^g   Rebe, Kevin ^e,f   Loyse, Angela ^a   Jarvis, Joseph ^a,d,e,f   Bekker, Linda Gail ^d   Wood, Robin ^d   Limmathurotsakul, Direk ⁱ   Chierakul, Wirongrong ⁱ   Stepniewska, Kasia ^c,i   White, Nicholas J ^c,i   Jaffar, Shabbar ^b   Harrison, Thomas S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Institute of Infectious Disease and Molecular Medicine   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f GF Jooste Hospital   (South Africa)

^g MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CYTOKINE; FLUCONAZOLE; FLUCYTOSINE; GAMMA INTERFERON;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CLEARANCE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPTOCOCCAL MENINGITIS; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOUTH AFRICA; THAILAND; UGANDA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CEREBROSPINAL FLUID; COHORT STUDIES; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; HUMANS; INTERFERON-GAMMA; MALE; MENINGITIS, CRYPTOCOCCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOUTH AFRICA; THAILAND; TIME FACTORS; TREATMENT OUTCOME; UGANDA;

EID: 70149095995     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/604716     Document Type: Article

References (22)

1. Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial. Lancet 2004; 363:1764-1767 (Pubitemid 38698379)
2. Lortholary O, Poizat G, Zeller V, et al. Long-term outcome of AIDSassociated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006;20:2183-2191 (Pubitemid 44684709)
3. Schaars CF, Meintjes GA, Morroni C, Post FA, Maartens G. Outcome of AIDS-assodated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole. BMC Infect Dis 2006; 6:118. (Pubitemid 46277110)
4. Bicanic T, Meintjes G, Wood R, et al. Fungal burden, clearance of infection, and outcome in cryptococcal meningitis in antiretroviralnai've and -experienced patients treated with amphotericin B or fluconazole. Clin. Infect Dis 2007;45:76-80. (Pubitemid 46984619)
5. Kambugu AD, Meya DB, Rhein J, et al. Outcomes of cryptocccal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008;46:1694-1701. (Pubitemid 351706766)
6. French N, Gray K, Watrea C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002; 16:1031-1038 (Pubitemid 34499426)
7. Okongo M., Morgan D, Mayanja B, Ross A, Whitworth J. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol 1998; 27: 698-702. (Pubitemid 28431516)
8. Corbett EL, Churchyard G, Charalambos S, et al. Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis 2002;34:1251-1258 (Pubitemid 34450674)
9. Saag MS, Powderly WG, Cloud GA, et al.; NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-89
10. van der Horst CM, Saag MS, Cloud GA, et al; National Institute of Allergy and Infectious Diseases Mycoses Study Group; AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997;337:15-21.
11. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-235 (Pubitemid 20045528)
12. Robinson PA, Bauer M, Leal ME, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999;28:82-92. (Pubitemid 29246130)
13. Bicanic T, Wood R, Meintjes G, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV: a randomized study. Clin Infect Dis 2008;47:123-130 (Pubitemid 351920599)
14. Longley N, Muzoora C, Taseera K, et al. Dose-response effect of high dose fluconazole for HIV-associated cryptococcal meningitis in southwest Uganda. Clin Infect Dis 2008;47:1556-1561
15. Siddiqui A, Brouwer AE, Wuthiekanun V, et al. Interferon-7 at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol 2005;174:1746-1750
16. Weir CJ, Walley R. Statistical evaluation of biomarkers as surrogate endpoints: a literature review. Stat Med 2006;25:183-203. (Pubitemid 43141502)
17. Larsen RA, Leal ME, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990;113:183-187 (Pubitemid 20242293)
18. Pappas PG, Bustamante B, Ticano E, et al. Recombinant interferonYl b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis 2004; 189:2185. (Pubitemid 38757190)
19. Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000; 30:47-54. (Pubitemid 30067061)
20. Bicanic T, Brouwer A, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 2009; 23: 70.1-6
21. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94:2435. (Pubitemid 24379619)
22. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144:480-484 (Pubitemid 20036072)